Search

everythinglearnresearchcommunity

for

Search:↓

Dutasteride more effectively treats hair loss than finasteride, but may increase risk of altered libido.

Men with benign prostatic hyperplasia are more likely to have metabolic syndrome than those without it.

Early onset baldness in men may indicate a condition similar to PCOS, linked to heart disease, diabetes, and prostate issues.

Finasteride affects prostate weights and pituitary activity differently with age.

Diagnosing hyperandrogenism in women is complex and requires accurate testing methods and consideration of SHBG levels.

DHT is a strong androgen that may pose less risk to the prostate compared to testosterone.

People with hair loss have worse cholesterol levels, possibly linking hair loss to heart problems.

5 alpha-reductase inhibitors like finasteride may lower prostate cancer risk and improve cancer screening.

People with certain types of alopecia have a slightly higher risk of cancer, especially thyroid, bladder, and prostate cancers.

Testosterone replacement therapy improved blood sugar and fat levels without raising prostate cancer risk in Japanese men with low testosterone.

Finasteride reduces prostate cancer risk by 30% without affecting Gleason scores.

Saw palmetto extract is generally safe and can effectively treat Lower Urinary Tract Symptoms, but its evaluation is affected by varying quality and a need for long-term studies.

Hair loss linked to kidney stones in people under 60.

Finasteride lowers good cholesterol, raises bad fats, and may increase heart disease risk.

Researchers developed a method to measure different forms of a drug that could help treat prostate issues and hair loss, and found how these forms behave in animals.

Precise objectives can improve student achievement in health education.

Men with androgenetic alopecia may have a higher risk of metabolic syndrome.

CT scans can find serious prostate cancer even when PSA levels are low.

The combination treatment reduced prostate size and improved testosterone deficiency symptoms but was less effective for sexual function.

Chemical fingerprints can distinguish Eclipta prostrata from Wedelia calendulacea to prevent confusion and adulteration.

Prostate cancer screening doesn't significantly reduce death rates and has risks like overdiagnosis and side effects.

Hair loss is a common, often overlooked side effect of hormone treatments for breast and prostate cancer.

There is no significant link between insulin resistance and certain hair disorders like idiopathic hirsutism and androgenic alopecia.

Hair loss is a common but often unreported side effect of cancer treatments, especially for breast and prostate cancers.

Testosterone replacement therapy improves libido, mood, muscle strength, and bone density in men with Testosterone Deficiency Syndrome.

Testosterone increases muscle mass regardless of DHT conversion blocking.

Urinary PSA could be an early marker for enlarged prostate.

Finasteride lowers PSA levels about the same whether taken at 1 mg or 5 mg daily.

Finasteride is popular for treating male hair loss but may increase the risk of serious prostate cancer and has other potential side effects.

DA-9401 protects against hair loss, improves organ function, and prevents infertility caused by finasteride.